By Alpit Patel and the aibrevo team · October 15, 2026 · 8 min read
Med Spa Lapsed Patient Reactivation Campaign: Define Lapsed by Treatment Cycle
A med spa lapsed patient reactivation campaign starts with a definition: a client is lapsed when they are overdue for their own treatment cycle, not when a calendar year has passed. Neurotoxin labels give a three-month minimum gap, so use that as a floor, add a grace period, and treat every other interval as an assumption your provider sets.
Part of the guide: Patient reactivation in GoHighLevel
Key takeaways
- The five neurotoxin labels we opened (Botox Cosmetic, Dysport, Xeomin, Jeuveau, Daxxify) each state a minimum retreatment gap of three months for their aesthetic indications. A minimum gap is a floor for when a client could be due, not a date after which they are lapsed.
- The Botox Cosmetic label says the duration of effect for glabellar lines is approximately 3 to 4 months. The Xeomin label says the typical duration is up to 12 to 16 weeks and varies by patient. Use those as context for your own cycle number, which your provider sets.
- We did not open instructions for use for dermal fillers, lasers or skin treatments for this page, so intervals for those are shown as editable assumptions, not facts.
- Define lapsed as days since last visit greater than cycle days plus a grace period. Segment into due soon, lapsed and long-lapsed, and give each a different message.
- Keep treatment names, doses and clinical detail out of the texts. Promotional texts need documented consent, and STOP must set Do Not Disturb.
The problem this page solves: a med spa lapsed patient reactivation campaign needs a definition of “lapsed”, and most spas have none, so the list is either everyone or arbitrary. Define it by treatment cycle first, then build the campaign. The system side (Smart Lists, workflow actions, send windows, measurement) lives on patient reactivation in GoHighLevel, part of our GoHighLevel expert for med spas guide. This page covers the definition, the segments and the message design.
Checked on October 15, 2026 against the current labels on NIH DailyMed and eCFR text for 47 CFR 64.1200 and 45 CFR 164.501. This is operations guidance, not medical or legal advice.
How do you define a lapsed patient by treatment cycle?
A client is lapsed when days since their last visit are greater than their cycle days plus a grace period. Write it as: lapsed if days since last visit > cycle days + grace days. Cycle days come from your provider and product information. Grace days are yours.
The reason to use a cycle is that clients return at different rhythms. A single “no visit in 12 months” rule leaves a recurring-treatment client unreached for most of a year after they could have rebooked, and it flags a once-a-year client who is perfectly on schedule.
Here is what we could source from the manufacturers’ own prescribing information. We pulled each label from DailyMed on October 15, 2026.
| Product (label owner, label date on DailyMed) | What the label says about repeat dosing | How to use it |
|---|---|---|
| Botox Cosmetic (Allergan, version published Jan 8, 2026) | Safety and effectiveness of dosing more frequently than every 3 months have not been clinically evaluated. Duration of effect for glabellar lines is approximately 3 to 4 months | Floor of 3 months; context for a 3 to 4 month cycle |
| Dysport (Galderma, Oct 28, 2024) | For glabellar lines, retreatment should be administered no more frequently than every 3 months | Floor of 3 months |
| Xeomin (Merz, Jul 13, 2026) | Retreatment for upper facial lines no more frequently than every three months. Typical duration of effect is up to 12 to 16 weeks and may vary | Floor of 3 months; typical duration up to 12 to 16 weeks |
| Jeuveau (Evolus, Dec 14, 2023) | Retreatment no more frequently than every three months | Floor of 3 months |
| Daxxify (Revance, Jan 8, 2026) | Should be administered no more frequently than every three months for any indication | Floor of 3 months |
Read the table carefully. These are minimum gaps, and for Botox Cosmetic and Xeomin, statements about how long an effect lasts on average. None says a client is overdue on a given day. That decision belongs to your medical provider and the client’s own history.
Interval assumptions for everything else, which you must set yourself:
| Service line | Cycle days (editable assumption) | Source to confirm |
|---|---|---|
| Neurotoxin | 120 (illustrative, from the 3 to 4 month Botox Cosmetic label statement) | Provider protocol |
| Dermal filler | Set by provider | Product instructions for use, which we did not open |
| Laser or energy-based series | Set by provider | Treatment plan |
| Facial and skin treatments | Set by provider | Your menu and plan |
Store these as a number custom field in HighLevel, as described on the system page, so each service line carries its own cycle and you can change it in one place.
What does a worked example look like?
This is illustrative arithmetic, not a recommendation. Assume a neurotoxin cycle of 120 days, which sits at the top of the 3 to 4 month Botox Cosmetic statement, and a grace period of 30 days. A client last seen 100 days ago is on schedule. At 120 days they are due. At 151 days they cross into lapsed.
| Days since last visit | Segment | Action |
|---|---|---|
| 0 to 105 | On schedule | Nothing |
| 106 to 150 | Due soon | One soft reminder with a booking link |
| 151 to 364 | Lapsed | The three-touch campaign below |
| 365 or more | Long-lapsed | One or two attempts, then rest |
Change every threshold to match your spa. The 14-day lead, 30-day grace and 365-day cutoff are assumptions.
How should a med spa lapsed patient reactivation campaign run?
Three touches, each shorter than the last, with an automatic stop. The timing below is our suggestion and has no sourced benchmark behind it, so test it. Judgment: the stop condition matters more than the copy, because a client who rebooked and still gets touch 3 is the failure that costs you trust.
- Touch 1, day 0 of lapsed. A friendly check-in with the booking link.
- Touch 2, about 7 days later, only if no reply or booking. A different angle, such as new availability.
- Touch 3, about 14 days after touch 1, only if no reply or booking. A last, low-pressure note that the door is open. Then tag the contact and rest.
Every touch ends the sequence for that client on booking, reply or STOP. The workflow actions that do this (Goal Event, Wait on reply, tags) are step by step on the system page.
What do good lapsed-client messages sound like?
Short, human and free of clinical detail. Merge in first name and the spa name only.
- Touch 1: “Hi {{first name}}, it’s {{spa name}}. It’s been a while and we’d love to see you. Book a time here: {{link}}. Reply STOP to opt out.”
- Touch 2: “Hi {{first name}}, we have new openings this month. Grab a time: {{link}}. Reply STOP to opt out.”
- Touch 3: “Hi {{first name}}, last note from us for now. Whenever you’re ready: {{link}}. Reply STOP to opt out.”
Avoid: the treatment name, the product name, a number of units, “your results are fading”, “time for your touch-up”, or anything about a prior reaction. Those phrases pair an identifiable person with their care, which is what 45 CFR 160.103 treats as individually identifiable health information when a covered entity creates it. More examples and the logic behind them are in med spa text messages without PHI.
Who must be excluded from the list?
Exclude anyone you cannot lawfully or safely message. Build the exclusions into the Smart List filters so a person cannot slip through.
| Exclude | How |
|---|---|
| Clients who opted out | SMS DND Enabled filter; see what DND is |
| Clients without documented promotional consent | Consent tag Is; see TCPA consent setup |
| Clients with a clinical hold or adverse event flag | A do-not-contact tag your provider sets |
| Clients already booked | Rebooked tag, or an appointment-status exit |
| Clients with an invalid or reassigned number | Delivery errors; see SMS error codes |
What consent and HIPAA rules apply?
Promotional texts need documented written consent, and STOP must set Do Not Disturb. Both are walked through in the TCPA setup guide and the DND answer. Sends must also stay inside lawful hours: 47 CFR 64.1200(c) bars telephone solicitation before 8 a.m. or after 9 p.m. at the called party’s location.
For HIPAA, a purely cash-pay med spa may or may not be a covered entity under 45 CFR 160.103. If you are, 45 CFR 164.501 defines marketing as a communication about a product or service that encourages purchase or use of it. Its exceptions include a communication to direct or recommend alternative treatments or to describe the entity’s own health-related services, but those exceptions do not apply where the entity receives financial remuneration from a third party whose product is being described. Counsel should decide how your campaign and any manufacturer loyalty program fit. For prescription treatments, also read our guide to advertising Botox and prescription treatments by text and email.
How do you know the campaign worked?
Count messaged, replied, booked and attended, and compare against a held-back group. Revenue is the attended visits. We found no sourced reactivation benchmark for med spas, so judge your results against your own pre-launch baseline and a holdout. The measurement table is on the system page.
Founder’s note, Alpit Patel. I see win-back texts go to people who already booked, and it costs trust. Define lapsed per service line before writing a single message: days since last visit greater than cycle days plus a grace period. A label’s three-month gap is a floor, not a due date. Test the stop condition first. A client who rebooked and still gets the third touch is the failure that costs trust. Keep treatment names out of the texts. I founded aibrevo in San Francisco in 2021, and through autoesta I have overseen 320+ GoHighLevel implementation projects across med spas, real estate, healthcare, dental, home services, SaaS and professional-services clients in the US, UK and UAE. About Alpit
Sources
All checked 2026-10-15.
- NIH DailyMed, Botox Cosmetic label (Allergan, version published Jan 8, 2026): dosing more frequently than every 3 months not clinically evaluated; duration of effect for glabellar lines approximately 3 to 4 months.
- NIH DailyMed, Dysport label (Galderma, Oct 28, 2024): glabellar lines retreatment no more frequently than every 3 months.
- NIH DailyMed, Xeomin label (Merz, Jul 13, 2026): upper facial lines retreatment no more frequently than every three months; typical duration up to 12 to 16 weeks.
- NIH DailyMed, Jeuveau label (Evolus, Dec 14, 2023): no more frequently than every three months.
- NIH DailyMed, Daxxify label (Revance, Jan 8, 2026): no more frequently than every three months for any indication.
- eCFR, 47 CFR 64.1200: calling hours (data through 2026-10-13).
- eCFR, 45 CFR 164.501 and 45 CFR 160.103: marketing, covered entity and individually identifiable health information.
- HighLevel Support, Advanced Filters in Smart Lists: Last Appointment At and DND filters used by the exclusions.